Sensyne signs Covid testing contract with DHSC

Sensyne Health CEO Paul Drayson
Paul Drayson, CEO, Sensyne Health

Clinical AI company Sensyne Health has signed a production contract with the UK’s Department of Health & Social Care (DHSC) to use its AI diagnostic lateral flow test reader, MagnifEye, as part of the government’s asymptomatic testing programme.   The contract is part of a phased national roll-out of testing over a three-month period in care…

You must be a HM Subscriber to view this content.

Subscribe Now »